Cite
Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression
MLA
Cho-Clark, Madelaine J., et al. “Comparative Transcriptome Analysis between Patient and Endometrial Cancer Cell Lines to Determine Common Signaling Pathways and Markers Linked to Cancer Progression.” Oncotarget, vol. 12, Dec. 2021, pp. 2500–13. EBSCOhost, https://doi.org/10.18632/oncotarget.28161.
APA
Cho-Clark, M. J., Sukumar, G., Vidal, N. M., Raiciulescu, S., Oyola, M. G., Olsen, C., Mariño-Ramírez, L., Dalgard, C. L., & Wu, T. J. (2021). Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression. Oncotarget, 12, 2500–2513. https://doi.org/10.18632/oncotarget.28161
Chicago
Cho-Clark, Madelaine J., Gauthaman Sukumar, Newton Medeiros Vidal, Sorana Raiciulescu, Mario G. Oyola, Cara Olsen, Leonardo Mariño-Ramírez, Clifton L. Dalgard, and T. John Wu. 2021. “Comparative Transcriptome Analysis between Patient and Endometrial Cancer Cell Lines to Determine Common Signaling Pathways and Markers Linked to Cancer Progression.” Oncotarget 12 (December): 2500–2513. doi:10.18632/oncotarget.28161.